| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8292723 | Biochemical and Biophysical Research Communications | 2018 | 5 Pages |
Abstract
PD-L1 mRNA can be detected and quantitated in ctRNA of cancer patients. These results pave the way for further studies aimed at determining whether monitoring the levels of PD-L1 mRNA in blood can identify patients who are most likely to benefit from the conventional treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Toshiyuki Ishiba, Andreas-Claudius Hoffmann, Joshua Usher, Yahya Elshimali, Todd Sturdevant, Mai Dang, Yolanda Jaimes, Rama Tyagi, Ronald Gonzales, Mary Grino, Jacek K. Pinski, Afsaneh Barzi, Luis E. Raez, Wilfried E. Eberhardt, Dirk Theegarten,